Literature DB >> 20973913

Long-term renal allograft survival in the United States: a critical reappraisal.

K E Lamb1, S Lodhi, H-U Meier-Kriesche.   

Abstract

Renal allograft survival has increased tremendously over past decades; this has been mostly attributed to improvements in first-year survival. This report describes the evolution of renal allograft survival in the United States where a total of 252 910 patients received a single-organ kidney transplant between 1989 and 2009. Half-lives were obtained from the Kaplan-Meier and Cox models. Graft half-life for deceased-donor transplants was 6.6 years in 1989, increased to 8 years in 1995, then after the year 2000 further increased to 8.8 years by 2005. More significant improvements were made in higher risk transplants like ECD recipients where the half-lives increased from 3 years in 1989 to 6.4 years in 2005. In low-risk populations like living-donor-recipients half-life did not change with 11.4 years in 1989 and 11.9 years in 2005. First-year attrition rates show dramatic improvements across all subgroups; however, attrition rates beyond the first year show only small improvements and are somewhat more evident in black recipients. The significant progress that has occurred over the last two decades in renal transplantation is mostly driven by improvements in short-term graft survival but long-term attrition is slowly improving and could lead to bigger advances in the future. ©2010 The Authors Journal compilation©2010 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2010        PMID: 20973913     DOI: 10.1111/j.1600-6143.2010.03283.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  259 in total

1.  Transplantation: Does anemia correction delay kidney allograft dysfunction?

Authors:  Edmund Huang; Suphamai Bunnapradist
Journal:  Nat Rev Nephrol       Date:  2012-02-28       Impact factor: 28.314

2.  Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.

Authors:  A D Kirk; A Guasch; H Xu; J Cheeseman; S I Mead; A Ghali; A K Mehta; D Wu; H Gebel; R Bray; J Horan; L S Kean; C P Larsen; T C Pearson
Journal:  Am J Transplant       Date:  2014-03-31       Impact factor: 8.086

3.  Value of solid organ transplant-trained pharmacists in transplant infectious diseases.

Authors:  Jennifer Trofe-Clark; Tiffany Kaiser; Nicole Pilch; David Taber
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

Review 4.  Understanding Medication Nonadherence after Kidney Transplant.

Authors:  Thomas E Nevins; Peter W Nickerson; Mary Amanda Dew
Journal:  J Am Soc Nephrol       Date:  2017-06-19       Impact factor: 10.121

5.  Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Authors:  Daniel E Weiner; Meyeon Park; Hocine Tighiouart; Alin A Joseph; Myra A Carpenter; Nitender Goyal; Andrew A House; Chi-Yuan Hsu; Joachim H Ix; Paul F Jacques; Clifton E Kew; S Joseph Kim; John W Kusek; Todd E Pesavento; Marc A Pfeffer; Stephen R Smith; Matthew R Weir; Andrew S Levey; Andrew G Bostom
Journal:  Am J Kidney Dis       Date:  2018-07-20       Impact factor: 8.860

6.  Relationship of Transforming Growth Factor-βl and Arginase-1 Levels with Long-term Survival after Kidney Transplantation.

Authors:  Xiao-Xiao Du; Yu-Liang Guo; Min Yang; Yan Yu; Sheng Chang; Bin Liu; Lan-Jun Cai; Zhong-Hua Klaus Chen
Journal:  Curr Med Sci       Date:  2018-06-22

Review 7.  Biomarkers in Solid Organ Transplantation.

Authors:  John Choi; Albana Bano; Jamil Azzi
Journal:  Clin Lab Med       Date:  2018-12-17       Impact factor: 1.935

8.  Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes.

Authors:  Jonathan S Bromberg; Lauren Hittle; Yanbao Xiong; Vikas Saxena; Eoghan M Smyth; Lushen Li; Tianshu Zhang; Chelsea Wagner; W Florian Fricke; Thomas Simon; Colin C Brinkman; Emmanuel F Mongodin
Journal:  JCI Insight       Date:  2018-10-04

9.  Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.

Authors:  Jordana B Cohen; Kevin C Eddinger; Kimberly A Forde; Peter L Abt; Deirdre Sawinski
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

Review 10.  Through a glass darkly: seeking clarity in preventing late kidney transplant failure.

Authors:  Mark D Stegall; Robert S Gaston; Fernando G Cosio; Arthur Matas
Journal:  J Am Soc Nephrol       Date:  2014-08-05       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.